Alexandria Real Estate Equities Inc. recently announced it has executed a 12-year lease with biotechnology company Genentech Inc. for a ground-up development of an approximately 121,000-square-foot facility in South San Francisco, Calif.
The value of the transaction was not disclosed.
Genentech is scheduled to take delivery of the four-story property in the fourth quarter of 2006, according to a press statement.
Alexandria Real Estate Equities Inc. is a publicly traded real estate investment trust focused on properties containing office/laboratory space.
You have {{data.cm.viewsLeft}} articles left this month.
This content is available to Inman Select subscribers.
Please select an option below.
Please register to access this content.
To continue viewing the content you love, please sign in or create a new account
You have used all of your free pageviews.
Please subscribe to access more content.
Access denied!